Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
New Urine Test Shows Promise for Early Detection of Bladder Cancer
1
Mins
June 2024
EarlyTect BCD, a new urine-based test, shows high clinical performance in detecting bladder cancer among haematuria patients.
Read more
5
Mins
24th September 2015
NICE Recommends Gilead’s Zydelig® (Idelalisib) for the Treatment of Chronic Lymphocytic Leukaemia
London, 24 September 2015 – Gilead Sciences’ Zydelig® (idelalisib) has today been recommended by the National Institute for Health and Care Excellence…
1
Mins
17th August 2015
More Reliable Prostate Cancer Diagnoses Provided by Sensor Chip
PROSTATE cancer (PrC) diagnosis may become more efficient and reliable thanks to a new sensor chip, according to recent study data.
1
Mins
17th August 2015
Disabling Ability of Lymphoma to Escape Immune Response May Trigger New Treatments
RESTORING the power of natural killer (NK) cells in the vicinity of lymphoma tumours may catalyse the development of new therapies, according to…
6
Mins
6th July 2015
Second-Line Cetuximab Active beyond Progression in Quadruple Wild-Type Patients with Metastatic Colorectal Cancer
BARCELONA-LUGANO, 4 July 2015 – Patients with metastatic colorectal cancer (mCRC) that are mutation-free in the KRAS, NRAS, BRAF and PIK3CA genes…
8
Mins
3rd July 2015
Studies Confirm Regorafenib Benefit in Pre-Treated Metastatic Colorectal Cancer
BARCELONA-LUGANO, 3 July 2015 – The phase IIIb CONSIGN study has confirmed the benefit of regorafenib in patients with previously treated…
4
Mins
2nd July 2015
Patients with Lowest BMI Have Shortest Survival in Pooled Analysis of Bevacizumab in Metastatic Colorectal Cancer
BARCELONA-LUGANO, 1 July 2015 – Patients with the lowest body mass index (BMI) had the shortest overall survival in an analysis of bevacizumab studies
1
Mins
18th May 2015
Are YOU at Increased Risk of Leukaemia?
INCREASED risk of acute lymphoblastic leukaemia (ALL) can be attributed to a genetic mutation in a similar manner to the BRCA1 mutation that can…
1
Mins
18th May 2015
Rise in Deadly Skin Cancer is by No Means Old News
SENIOR citizens in Britain are approximately seven times more likely to develop malignant melanoma than they were 40 years ago, according to new statistics.
Loading posts...
« Previous
1
…
27
28
29
30
31
32
Next »